Table 1.
Baseline characteristics of the 294 participants
| Variables | n (%) |
|---|---|
| Gender | |
| Female | 211 (71.8) |
| Male | 83 (28.2) |
| Age, years | |
| 18–40 | 105 (35.7) |
| >40 | 189 (64.3) |
| Disease type | |
| UC | 148 (50.3) |
| CD | 146 (49.7) |
| Disease activity | |
| Remission | 214 (72.8) |
| Transitional stage | 53 (18.0) |
| Relapse | 27 (9.2) |
| Disease duration, years | |
| ≤5 | 71 (24.1) |
| 6–10 | 76 (25.9) |
| 11–20 | 79 (26.9) |
| ≥21 | 68 (23.2) |
| Medication | |
| Mesalazine | 123 (41.8) |
| Immunosuppressives | 117 (39.8) |
| Biologicals | 71 (24.1) |
| Corticosteroids | 48 (16.3) |
| No medicine | 38 (12.9) |
| Other medication | 36 (12.2) |
UC, ulcerative colitis; CD, Crohn's disease.